Glimiron MP 2mg/500mg/15mg Tablet
By Glimiron MP
Rx
10 Tablet in a Strip

Composition
Glimepiride(2mg) + Metformin(500mg) + Pioglitazone(15mg)

Manufacturer - Kentreck Laboratories Pvt Ltd
207, Anand Mangal Complax, B/h. Omkar House, Nr. Swastik Char Rasta, Navrangpura, Ahmedabad - 380 009.

Expires on or after
September, 2025

liver
When taking Glimiron MP 2mg/500mg/15mg Tablet, it's important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment while using this medication. It is crucial to consult your doctor before starting or continuing treatment with Glimiron MP 2mg/500mg/15mg Tablet. Note that individuals with severe liver disease are advised not to use this medication. If you have any concerns about how Glimiron MP 2mg/500mg/15mg Tablet may affect your liver condition, speak to your healthcare provider promptly.

kidney
Caution Glimiron MP 2mg/500mg/15mg Tablet should be used carefully in patients with kidney problems. Your doctor may adjust the dose as needed. Avoid using if you have severe kidney disease. Regular kidney function tests are recommended during treatment.

alcohol
It is not safe to drink alcohol while taking Glimiron MP 2mg/500mg/15mg Tablet. Drinking alcohol may worsen side effects. Consult your doctor when consuming alcohol with Glimiron MP 2mg/500mg/15mg Tablet.

driving
When taking Glimiron MP 2mg/500mg/15mg Tablet, be cautious while driving. Low or high blood sugar can impact your ability to drive safely. Avoid driving if experiencing symptoms related to blood sugar levels to ensure safety on the road.

pregnancy
Glimiron MP 2mg/500mg/15mg Tablet is considered unsafe during pregnancy. Animal studies have shown potential harm to the developing baby. It's important to discuss with your doctor about the benefits and risks before using this medication.

breastfeeding
Caution is advised when using Glimiron MP 2mg/500mg/15mg Tablet during breastfeeding as it may be unsafe. Limited data indicates potential harm to the baby through the drug passing into breastmilk.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹97.3
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 18-Nov-2024